We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current APRE market cap is 13.6M. The company's latest EPS is USD -30.1504 and P/E is -0.12.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 250k |
| Operating Income | -98.47M | -4.2M | -2.65M | -4.62M | -3.65M |
| Net Income | -98.26M | -4.03M | -2.44M | -4.38M | -3.26M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -16.49M | -29.54M | -52.81M | -37.45M | -113.39M |
| Net Income | -15.53M | -28.06M | -53.48M | -37.13M | -112.66M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 40.68M | 33.62M | 30.16M | 32.02M | 28.68M |
| Total Liabilities | 7.68M | 4M | 3.2M | 4.23M | 3.95M |
| Total Equity | -35.78M | 26.63M | 25.64M | 26.48M | 23.42M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 66.02M | 133.61M | 92.81M | 56.82M | 30.16M |
| Total Liabilities | 4.87M | 9.36M | 15.41M | 7.32M | 3.2M |
| Total Equity | -51.44M | 124.24M | 77.4M | 49.51M | 25.64M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -14.4M | -20.99M | -25.01M | -2.98M | -6.2M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | N/A | 585k | 683k | 5.14M | 5.14M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -15.25M | -26.71M | -41.8M | -37.69M | -25.01M |
| Investing | -4k | -31k | -26k | N/A | N/A |
| Financing | 56.37M | 92.58M | 151k | 1.75M | 683k |
| Market Cap | 13.6M |
| Price to Earnings Ratio | -0.12 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.47 |
| Price to Book Ratio | 0.5 |
| Dividend Yield | - |
| Shares Outstanding | 3.74M |
| Average Volume (1 week) | 5.08k |
| Average Volume (1 Month) | 4.92k |
| 52 Week Change | -51.85% |
| 52 Week High | 12.00 |
| 52 Week Low | 2.78 |
| Spread (Intraday) | 0.26 (6.67%) |
| Company Name | Aprea Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.aprea.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: 1-888-992-3836 | help@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
